Get the Stockscreener App
9.57
3.57%
0.33
After Hours:
9.48
-0.09
-0.94%
Advanced Biomed Inc stock is traded at $9.57, with a volume of 371.76K.
It is up +3.57% in the last 24 hours and down -33.36% over the past month.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
See More
Previous Close:
$9.24
Open:
$9.05
24h Volume:
371.76K
Relative Volume:
0.25
Market Cap:
$15.81M
Revenue:
-
Net Income/Loss:
$174.50K
P/E Ratio:
60.11
EPS:
0.1592
Net Cash Flow:
$-102.70K
1W Performance:
+16.85%
1M Performance:
-33.36%
6M Performance:
+135.58%
1Y Performance:
+17.28%
1-Day Range:
$8.60
$9.75
1-Week Range:
$7.20
$10.01
52-Week Range:
$3.61
$24.23
Advanced Biomed Inc Stock (ADVB) Company Profile
Name
Advanced Biomed Inc
Sector
Industry
Phone
86-21-20510823
Address
401 RYLAND ST, RENO
Compare ADVB vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADVB
Advanced Biomed Inc
|
9.57 | 13.53M | 0 | 174.50K | -102.70K | 0.1592 |
TMO
Thermo Fisher Scientific Inc
|
630.70 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.68 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
338.70 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
157.69 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.38 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
Advanced Biomed Inc Stock (ADVB) Latest News
Advanced Biomed Company Profile & Introduction - Moomoo
Advanced Biomed (ADVB) insider transfers 176K shares to repay $480K debt - Stock Titan
Advanced Biomed (ADVB) investor gives up entire stake to clear $480K debt - Stock Titan
Single investor now owns 12.75% of Advanced Biomed (ADVB) - Stock Titan
Orchestra BioMed Loss Widens as Pivotal Trials Advance - MyChesCo
Advanced Biomed Inc. (ADVB) Gains 4.31% to $8.95 as Shares Approach Key ResistanceDip Buy Trade - vinanet.vn
Advanced Biomed (ADVB) Climbs 4.31% to $8.95, Approaching Key Resistance at $9.40Double Bottom - vinanet.vn
US Micro Cap StocksInvest from India - INDmoney
Advanced Biomed(ADVB) Stock Options Chain | Quotes & News - Moomoo
Varonis Systems (VRNS) Climbs 3% as Data Security Momentum BuildsVWAP Breakout - Vinanet
Advanced Biomed Inc (ADVB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Advanced Biomed Inc (ADVB) Stock News Today - TradingKey
Advanced Biomed Inc. (ADVB) Tumbles 14.38% to $6.37: Key Support in FocusEqual Weight ETF - vinanet.vn
Advanced Biomed (ADVB) Slips 5.5% to $7.55 as Support at $7.17 Comes Into FocusSign of Strength - vinanet.vn
Hyatt Hotels (H) Edges Higher to $174 Amid Resilient Hospitality DemandAAII Neutral - Vinanet
Advanced Biomed (ADVB) Tumbles 20.6% to $8.0 as Biotech Selloff IntensifiesSpring Pattern - dars.gov.et
Advanced Biomed (ADVB) Drops 14.98% to $8.57, Testing Critical $8.14 SupportMoney Flow - dars.gov.et
Advanced Biomed Inc (ADVB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ADVB|Advanced Biomed Inc|Price:14.415|Chg%:-4.565 - TradingKey
ADVB | Advanced Biomed Inc. Common Insider Trading - Quiver Quantitative
Advanced Biomed Inc (ADVB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Advanced Biomed Inc (ADVB) Balance Sheet - TradingKey
Advanced Biomed Inc (ADVB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ADVB|Advanced Biomed Inc|Price:14.250|Chg%:-4.730 - TradingKey
Advanced Biomed Inc (ADVB) Institutional Confidence - TradingKey
Advanced Biomed Inc (ADVB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Advanced Biomed Inc (ADVB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Advanced Biomed Inc (ADVB) Cash Flow - TradingKey
ADVB|Advanced Biomed Inc|Price:7.480|Chg%:-0.460 - TradingKey
Advanced Biomed (ADVB) Stock Forum and Discussion - Moomoo
Advanced Biomed Inc. Revenue Breakdown – NASDAQ:ADVB - TradingView
ADVB|Advanced Biomed Inc|Price:12.510|Chg%:-1.850 - TradingKey
On Friday, there are stocks with unusual volume. Let's take a look. - ChartMill
Morning Market Movers: SAFT, ZVRA, RBNE, ADVB See Big Swings - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Biotech Stocks Surge with Advanced Biomed Leading Gains - Intellectia AI
Stocks rise on strong earnings, reverse splits, leadership changes, and inverse ETF bets. - Pluang
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Unusual volume stocks are being observed in Thursday's session. - ChartMill
3 Penny Stocks to Watch Today, 7/23/2026 - TipRanks
FRNM Price Today: Freenome, Inc. Stock Price, Quote & Chart - MEXC
Advanced Biomed Inc. (ADVB) Surges 36.98%: Key Levels and Volume CluesStock News - dars.gov.et
BXBL Price Today: BOXABL, Inc. Stock Price, Quote & Chart - MEXC
N-Zyme Biomedical Raises $4.6 Million Series A To Advance Reflux Disease Treatments - Pulse 2.0
PN Smart Energy and Advanced Biomed lead market gains with major contracts and stock splits. - Pluang
Zhibao stock jumps after 3,500-bitcoin PIPE; specifics on dilution still not disclosed - TechStock²
Advanced Biomed Inc. (NASDAQ:ADVB) jumps as $25 million equity facility concludes - TechStock²
Advanced Biomed stock is surging: Here's why it is trending - MSN
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
These stocks have an unusual volume in today's session - ChartMill
N-Zyme Biomedical Raises $4.6 Million Series A to Advance Phase 2 Reflux Disease Programs - citybiz
Advanced Biomed Inc Stock (ADVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):